✦ LIBER ✦

Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials

✍ Scribed by H. Jacobsen; M. Haenggi; M. Ott; I.B. Duncan; M. Andreoni; S. Vella; J. Mous

Book ID: 113259126
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 167 KB
Volume: 29
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(95)00927-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An update on bronchodilators in Phase I

An update on bronchodilators in Phase I and II clinical trials

✍ Cazzola, Mario; Rogliani, Paola; Segreti, Andrea; Matera, Maria Gabriella 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 296 KB

Update on the Talent aortic stent-graft:

Update on the Talent aortic stent-graft: A preliminary report from United States phase I and II trials

✍ Criado, Frank J.; Wilson, Eric P.; Fairman, Ronald M.; Abul-Khoudoud, Omran; Wel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Telomerase Peptide Vaccination in NSCLC:

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial

✍ Brunsvig, P. F.; Kyte, J. A.; Kersten, C.; Sundstrom, S.; Moller, M.; Nyakas, M. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 788 KB

An Update on Correlative Molecular Endpo

An Update on Correlative Molecular Endpoints from RTOG 0211: Phase I/II Study of Gefitinib + Radiation for Newly Diagnosed Glioblastoma Patients

✍ A. Chakravarti; M. Wang; P. Mischel; H.I. Robins; A. Guha; M. Machtay; W. Curran 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

214 POSTER AP5346 (ProLindacTM), a pH-de

214 POSTER AP5346 (ProLindacTM), a pH-dependent polymer-vectorized DACH platinum, is active in borderline potentially platinum-sensitive ovarian cancer (OC) patients: results from an ongoing Phase I/II trial

✍ F. Joly; A. Madroszyk; A. Floquet; D. Gedouin; F. Bourdel; M. Campone 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

The impact of induction duration and the

The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: An analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program

✍ A.D Elias; J Ibrahim; P Richardson; D Avigan; R Joyce; E Reich; M McCauley; C Wh 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB